Advertisement

Topics

Treatment of cutaneous T cell lymphoma

08:25 EDT 6 Sep 2016 | ecancermedicalscience

Dr Duvic speaks with ecancertv at WCCS 2016 about mogamulizumab, an anti-CCR4 engineered antibody for treatment of cutaneous T cell lymphoma, also known as Sézary syndrome She reports on results from a phase I/II trial in which patient response rate...

Original Article: Treatment of cutaneous T cell lymphoma

NEXT ARTICLE

More From BioPortfolio on "Treatment of cutaneous T cell lymphoma"

Quick Search
Advertisement
 

Relevant Topic

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...